Phase Ia first-in-human study of XmAb 5871 in healthy adult men.
Phase of Trial: Phase I
Latest Information Update: 13 Feb 2013
At a glance
- Drugs XmAb 5871 (Primary)
- Indications Rheumatoid arthritis; Systemic lupus erythematosus
- Focus Adverse reactions
- 13 Feb 2013 Status changed from recruiting to completed, based on a Xencor media release.
- 10 Mar 2011 New trial record